Product Information
QUILLICHEW ER 40 MG CHEW TAB is a brand product labeled by NextWave Pharmaceuticals, Inc, priced at $11.8720 per EA under NDC 24478007601. Its NADAC has been published 415 times since Oct 24, 2018.
FDA first approved this application on Dec 4, 2015.
Strength
40 mg/1
Manufacturer
NextWave Pharmaceuticals, IncNDC
24478007601
Classification
Brand
Dosage Form
TABLET, CHEWABLE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA207960FDA Approved
12/4/2015
On Market Since
4/18/2016
Pharmacological Classes
Price Statistics
The NADAC for QUILLICHEW ER 40 MG CHEW TAB has been published 415 times since Oct 24, 2018, and over the history we have for it it has risen 15.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.8720 per EA |
|---|---|
| All-time high | $11.9485 (Mar 13, 2024) |
| All-time low | $10.3249 (Oct 24, 2018) |
| 52-week high | $11.8883 |
| 52-week low | $11.8720 |
| Median price | $11.8878 |
| Average price | $11.6215 |
| Largest weekly change | +6.0% (Jan 8, 2020) |
| Weeks tracked | 415 |
| Tracking since | Oct 24, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the methylphenidate hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NextWave Pharmaceuticals, Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
methylphenidate hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QUILLICHEW ER 40 MG CHEW TAB?
The current National Average Drug Acquisition Cost (NADAC) for QUILLICHEW ER 40 MG CHEW TAB, manufactured by NextWave Pharmaceuticals, Inc, is $11.8720 per EA (NDC 24478007601), effective Sep 30, 2026.
How has the price of QUILLICHEW ER 40 MG CHEW TAB changed over time?
Over the history we have for it, the NADAC for QUILLICHEW ER 40 MG CHEW TAB has risen 15.0%. It has been tracked across 415 weekly CMS publications since Oct 24, 2018.
What are the highest and lowest recorded NADAC prices for QUILLICHEW ER 40 MG CHEW TAB?
Since Oct 24, 2018, the NADAC for QUILLICHEW ER 40 MG CHEW TAB has ranged from a low of $10.3249 (Oct 24, 2018) to a high of $11.9485 (Mar 13, 2024), with a median of $11.8878 per EA.
Are there cheaper alternatives to QUILLICHEW ER 40 MG CHEW TAB?
No other NADAC-published product currently shares the active ingredient and strength of QUILLICHEW ER 40 MG CHEW TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QUILLICHEW ER 40 MG CHEW TAB?
QUILLICHEW ER 40 MG CHEW TAB (NDC 24478007601) is labeled by NextWave Pharmaceuticals, Inc, and CMS classifies it as a brand product.